Bank of America’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.9M Buy
143,609
+83,598
+139% +$8.91M ﹤0.01% 2629
2025
Q4
$6.19M Buy
60,011
+9,249
+18% +$900K ﹤0.01% 3215
2025
Q3
$4.59M Sell
50,762
-8,875
-15% -$777K ﹤0.01% 4095
2025
Q2
$5.25M Sell
59,637
-118,459
-67% -$10.3M ﹤0.01% 3849
2025
Q1
$16.2M Buy
178,096
+68,859
+63% +$6.2M ﹤0.01% 2675
2024
Q4
$9.42M Buy
109,237
+5,447
+5% +$493K ﹤0.01% 3004
2024
Q3
$9.86M Buy
103,790
+13,978
+16% +$1.33M ﹤0.01% 3084
2024
Q2
$8.22M Sell
89,812
-318,781
-78% -$28.5M ﹤0.01% 3146
2024
Q1
$37.1M Sell
408,593
-216,701
-35% -$19M ﹤0.01% 1716
2023
Q4
$50.9M Sell
625,294
-43,323
-6% -$3.4M 0.01% 1353
2023
Q3
$53.4M Sell
668,617
-345,811
-34% -$27.9M 0.01% 1243
2023
Q2
$79.9M Buy
1,014,428
+236,284
+30% +$18.5M 0.01% 1004
2023
Q1
$60.4M Buy
778,144
+480,478
+161% +$37M 0.01% 1233
2022
Q4
$23.1M Buy
297,666
+215,344
+262% +$15.9M ﹤0.01% 1899
2022
Q3
$5.54M Sell
82,322
-10,841
-12% -$799K ﹤0.01% 3238
2022
Q2
$7.16M Buy
93,163
+64,748
+228% +$5.05M ﹤0.01% 3013
2022
Q1
$2.27M Sell
28,415
-12,267
-30% -$939K ﹤0.01% 4464
2021
Q4
$3.13M Sell
40,682
-84,459
-67% -$6.28M ﹤0.01% 4116
2021
Q3
$9.11M Sell
125,141
-40,207
-24% -$3M ﹤0.01% 2954
2021
Q2
$12.1M Sell
165,348
-359,726
-69% -$25.7M ﹤0.01% 2637
2021
Q1
$36.2M Buy
525,074
+495,137
+1,654% +$34.1M ﹤0.01% 1542
2020
Q4
$1.99M Sell
29,937
-499,884
-94% -$32M ﹤0.01% 3953
2020
Q3
$32.9M Buy
529,821
+499,478
+1,646% +$31.6M ﹤0.01% 1339
2020
Q2
$1.89M Sell
30,343
-85,035
-74% -$5.14M ﹤0.01% 3671
2020
Q1
$6.28M Buy
115,378
+73,212
+174% +$4.51M ﹤0.01% 2463
2019
Q4
$2.71M Sell
42,166
-801,872
-95% -$48.3M ﹤0.01% 3780
2019
Q3
$48.1M Buy
844,038
+721,767
+590% +$41.3M 0.01% 1153
2019
Q2
$7.17M Buy
122,271
+66,917
+121% +$3.87M ﹤0.01% 2879
2019
Q1
$3.36M Sell
55,354
-18,719
-25% -$1.11M ﹤0.01% 3544
2018
Q4
$4.06M Sell
74,073
-2,175
-3% -$132K ﹤0.01% 3219
2018
Q3
$4.91M Sell
76,248
-2,351
-3% -$147K ﹤0.01% 3196
2018
Q2
$4.64M Sell
78,599
-76,586
-49% -$4.44M ﹤0.01% 3236
2018
Q1
$8.82M Buy
155,185
+63,660
+70% +$3.8M ﹤0.01% 2526
2017
Q4
$5.43M Sell
91,525
-1,130,842
-93% -$64.8M ﹤0.01% 3048
2017
Q3
$70.6M Buy
1,222,367
+1,150,456
+1,600% +$65.3M 0.01% 929
2017
Q2
$4.25M Sell
71,911
-13,553
-16% -$767K ﹤0.01% 3193
2017
Q1
$4.71M Sell
85,464
-36,963
-30% -$2M ﹤0.01% 3087
2016
Q4
$6.43M Buy
122,427
+91,075
+290% +$4.87M ﹤0.01% 2694
2016
Q3
$1.8M Sell
31,352
-463
-1% -$27.8K ﹤0.01% 3721
2016
Q2
$1.86M Sell
31,815
-381
-1% -$22.2K ﹤0.01% 3688
2016
Q1
$1.85M Sell
32,196
-58,615
-65% -$3.47M ﹤0.01% 3635
2015
Q4
$5.93M Buy
90,811
+43,029
+90% +$2.78M ﹤0.01% 2773
2015
Q3
$3.01M Buy
47,782
+261
+0.5% +$18.3K ﹤0.01% 3385
2015
Q2
$3.36M Buy
47,521
+2,706
+6% +$195K ﹤0.01% 2963
2015
Q1
$3.15M Sell
44,815
-6,119
-12% -$415K ﹤0.01% 2849
2014
Q4
$3.27M Sell
50,934
-32,823
-39% -$2.09M ﹤0.01% 2921
2014
Q3
$5.32M Buy
83,757
+3,026
+4% +$187K ﹤0.01% 2524
2014
Q2
$5.01M Sell
80,731
-6,142
-7% -$365K ﹤0.01% 2560
2014
Q1
$5.07M Buy
86,873
+8,696
+11% +$492K ﹤0.01% 2367
2013
Q4
$4.15M Buy
78,177
+33,836
+76% +$1.71M ﹤0.01% 2632
2013
Q3
$2.12M Sell
44,341
-2,862
-6% -$136K ﹤0.01% 3216
2013
Q2
$2.15M Buy
+47,203
New +$2.18M ﹤0.01% 3125

Other funds holding PPH

Bank of America's PPH Position: Q1 2026 in Review

Bank of America increased its VanEck Pharmaceutical ETF (PPH) stake by 139% in Q1 2026, buying an estimated $8.91M and bringing the position to 143,609 shares worth $14.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2629.

Bank of America first reported a position in PPH in Q2 2013 and has held it in 52 quarters since. The position peaked at $79.9M in Q2 2023. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

  • Bank of America held 143,609 shares of VanEck Pharmaceutical ETF worth $14.9M as of Q1 2026.
  • Bank of America bought 83,598 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $8.91M.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2629 holding.
  • Bank of America first reported a position in VanEck Pharmaceutical ETF in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's VanEck Pharmaceutical ETF position peaked at $79.9M in Q2 2023.
  • 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.